Eissa Sanaa, Ahmed Maha Imam, Said Heba, Zaghlool Ashraf, El-Ahmady Omar
Oncology Diagnostic Unit, Medical Biochemistry Department, Ain Shams Faculty of Medicine, Cairo, Egypt.
IUBMB Life. 2004 Sep;56(9):557-64. doi: 10.1080/15216540400013903.
Dysregulation of cell cycle control may lead to genomic instability, neoplastic transformation and tumor progression. In terms of the particular roles in regulation of the cell-cycle, p21(WAF1) causes growth arrest through inhibition of cyclin-dependant kinases required for G1/S transition. P16 (INK4A) and p15 (INK4B) are thought to act as tumor suppressors, since their inactivation and/or deletion are observable in various types of malignancies. Cyclin D1 is hypothesized to control cell cycle progression through the G1-S check point. The present study evaluated p21 expression, p16 and p15 gene deletion and cylin D1 expression in bladder carcinoma among Egyptian patients, in relation to different clinicopathological features of the tumors and presence or absence of bilharziasis. Tissue specimens were obtained from 132 patients with bladder carcinoma and 50 normal tissue samples from the same patients served as control. P21 was determined by Western blot (WB) and enzyme immunoassay (EIA), p16 and p15 gene deletions were examined by polymerase chain reaction (PCR) and Cyclin D1 was detected by WB. Levels of p21 were lower in malignant tumors than in normal tissues. Lower expression of p21 was evident in lymph node positive, well differentiated tumors and squamous cell carcinoma (SCC) than in lymph node negative, poorly differentiated tumors and transitional cell carcinoma (TCC). In all normal samples, p15 and p16 genes were detected while cyclin D1 was not detected. P16 and p15 genes were deleted in 38.7% (41/106) and 30.2% (32/106) of bladder tumors respectively. The deletion of both genes was associated with poor differentiation grade and presence of bilharziasis. P16 deletion was also correlated to advancing tumor stage. Cyclin D1 was expressed in 57.5% of bladder tumors (69/120), where its expression was correlated to early stage, well differentiation grade, schistomiasis, and low levels of p21. Cell cycle is dysregulated in bladder carcinoma. This was evident from the increased expression of cyclin D1, the decreased levels of p21 and the deletion of p15 and p16 genes. Moreover, p16 and p15 gene deletion was related to tumor progression and might have a role in bilharzial bladder carcinogenesis. Cyclin D1 over-expression appears to be an early event in bladder cancer and might explain bilharzial associated bladder carcinogenesis.
细胞周期调控失调可能导致基因组不稳定、肿瘤转化和肿瘤进展。就其在细胞周期调控中的特定作用而言,p21(WAF1)通过抑制G1/S期转换所需的细胞周期蛋白依赖性激酶导致生长停滞。P16(INK4A)和p15(INK4B)被认为是肿瘤抑制因子,因为在各种类型的恶性肿瘤中都可观察到它们的失活和/或缺失。细胞周期蛋白D1被推测通过G1-S检查点控制细胞周期进程。本研究评估了埃及膀胱癌患者中p21的表达、p16和p15基因缺失以及细胞周期蛋白D1的表达,以及与肿瘤的不同临床病理特征和是否存在血吸虫病的关系。从132例膀胱癌患者获取组织标本,并从同一患者身上获取50份正常组织样本作为对照。通过蛋白质免疫印迹法(WB)和酶免疫测定法(EIA)测定p21,通过聚合酶链反应(PCR)检测p16和p15基因缺失,通过WB检测细胞周期蛋白D1。恶性肿瘤中p21水平低于正常组织。与淋巴结阴性、低分化肿瘤和移行细胞癌(TCC)相比,淋巴结阳性、高分化肿瘤和鳞状细胞癌(SCC)中p21表达较低。在所有正常样本中,检测到p15和p16基因,而未检测到细胞周期蛋白D1。在106例膀胱肿瘤中,分别有38.7%(41/106)和30.2%(32/106)的肿瘤发生p16和p15基因缺失。这两个基因的缺失与低分化程度和血吸虫病的存在有关。P16基因缺失也与肿瘤分期进展相关。细胞周期蛋白D1在57.5%的膀胱肿瘤(69/120)中表达,其表达与早期、高分化程度、血吸虫病以及低水平的p21相关。膀胱癌中细胞周期失调。这从细胞周期蛋白D1表达增加、p21水平降低以及p15和p16基因缺失中明显可见。此外,p16和p15基因缺失与肿瘤进展相关,可能在血吸虫性膀胱癌发生中起作用。细胞周期蛋白D1过表达似乎是膀胱癌的早期事件,可能解释血吸虫相关的膀胱癌发生。